loading
前日終値:
$42.26
開ける:
$42.8
24時間の取引高:
1.11M
Relative Volume:
0.75
時価総額:
$7.64B
収益:
$29.52M
当期純損益:
$-567.06M
株価収益率:
-11.30
EPS:
-3.66
ネットキャッシュフロー:
$-551.11M
1週間 パフォーマンス:
+1.65%
1か月 パフォーマンス:
+2.94%
6か月 パフォーマンス:
-8.70%
1年 パフォーマンス:
+41.72%
1日の値動き範囲:
Value
$41.26
$42.94
1週間の範囲:
Value
$40.71
$42.94
52週間の値動き範囲:
Value
$28.64
$62.40

Revolution Medicines Inc Stock (RVMD) Company Profile

Name
名前
Revolution Medicines Inc
Name
セクター
Healthcare (1169)
Name
電話
415-766-3638
Name
住所
700 SAGINAW DR, REDWOOD CITY, CA
Name
職員
490
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
RVMD's Discussions on Twitter

RVMD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RVMD
Revolution Medicines Inc
41.34 7.64B 29.52M -567.06M -551.11M -3.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-07-16 繰り返されました Needham Buy
2024-07-12 開始されました Barclays Overweight
2024-07-08 開始されました Jefferies Buy
2024-04-12 繰り返されました Needham Buy
2024-04-10 アップグレード Raymond James Outperform → Strong Buy
2024-03-11 開始されました Piper Sandler Overweight
2024-01-05 アップグレード BofA Securities Neutral → Buy
2024-01-04 開始されました Wedbush Outperform
2023-11-16 開始されました Raymond James Outperform
2023-02-28 アップグレード JP Morgan Neutral → Overweight
2022-12-14 開始されました Needham Buy
2022-10-21 開始されました Oppenheimer Outperform
2022-05-20 開始されました BofA Securities Neutral
2022-03-01 アップグレード Stifel Hold → Buy
2021-09-23 開始されました Stifel Hold
2021-08-12 ダウングレード Goldman Buy → Neutral
2021-05-18 開始されました Goldman Buy
2020-05-21 開始されました H.C. Wainwright Buy
2020-03-09 開始されました Cowen Outperform
2020-03-09 開始されました Guggenheim Buy
2020-03-09 開始されました JP Morgan Neutral
すべてを表示

Revolution Medicines Inc (RVMD) 最新ニュース

pulisher
Feb 19, 2025

Revolution Medicines to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq

Feb 19, 2025
pulisher
Feb 19, 2025

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025 - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Revolution Medicines to Report Financial Results for Fourth - GlobeNewswire

Feb 19, 2025
pulisher
Feb 19, 2025

Revolution Medicines Q4 Earnings Coming: Will Their Cancer Drug Pipeline Show Progress? - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

(RVMD) Proactive Strategies - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 17, 2025

Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials - MSN

Feb 17, 2025
pulisher
Feb 15, 2025

Wilmington Savings Fund Society FSB Sells 15,167 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

SG Americas Securities LLC Sells 28,515 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Empowered Funds LLC Purchases New Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Mirae Asset Global Investments Co. Ltd. Sells 435 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - Defense World

Feb 14, 2025
pulisher
Feb 14, 2025

Wingate Wealth Advisors Inc. Buys New Stake in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

WCM Investment Management LLC Takes $6.80 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 13, 2025
pulisher
Feb 10, 2025

Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect? - MSN

Feb 10, 2025
pulisher
Feb 08, 2025

(RVMD) Trading Advice - Stock Traders Daily

Feb 08, 2025
pulisher
Feb 08, 2025

Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Feb 08, 2025
pulisher
Feb 07, 2025

12 Best Healthcare Stocks to Buy According to Analysts - Insider Monkey

Feb 07, 2025
pulisher
Feb 07, 2025

Revolution Medicines Inc [RVMD] stock for 97,443 USD was sold by Cislini Jeff - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Stock Performance Spotlight: Revolution Medicines Inc (RVMD) Ends the Day at 43.57, Down by -1.54 - The Dwinnex

Feb 07, 2025
pulisher
Feb 06, 2025

An analyst sees good growth prospects for Revolution Medicines Inc (RVMD) - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Revolution Medicines, Inc. (NASDAQ:RVMD) Stake Lifted by KBC Group NV - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

China Universal Asset Management Co. Ltd. Buys 29,853 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Revolution Medicines' SWOT analysis: stock shows promise amid cancer treatment advances - MSN

Feb 04, 2025
pulisher
Feb 03, 2025

Revolution Medicines’ SWOT analysis: stock shows promise amid cancer treatment advances - Investing.com Nigeria

Feb 03, 2025
pulisher
Feb 03, 2025

Revolution Medicines' SWOT analysis: stock shows promise amid cancer treatment advances By Investing.com - Investing.com South Africa

Feb 03, 2025
pulisher
Feb 03, 2025

Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Are Investors Undervaluing Revolution Medicines, Inc. (NASDAQ:RVMD) By 49%? - Simply Wall St

Feb 03, 2025
pulisher
Jan 31, 2025

Is Revolution Medicines, Inc. (NASDAQ:RVMD) Trading At A 49% Discount? - Yahoo Finance

Jan 31, 2025
pulisher
Jan 30, 2025

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.25 Average Target Price from Brokerages - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference - The Manila Times

Jan 29, 2025
pulisher
Jan 29, 2025

RAS Cancer Breakthrough? Revolution Medicines CEO Takes Center Stage at Major Biotech Event - StockTitan

Jan 29, 2025
pulisher
Jan 28, 2025

Revolution Medicines: New Data Underscore A True Cancer Revolution (Upgrade) - Seeking Alpha

Jan 28, 2025
pulisher
Jan 27, 2025

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.25 Average Target Price from Analysts - MarketBeat

Jan 27, 2025
pulisher
Jan 24, 2025

Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround - MSN

Jan 24, 2025
pulisher
Jan 23, 2025

Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials By Investing.com - Investing.com South Africa

Jan 23, 2025
pulisher
Jan 22, 2025

Revolution Medicines general counsel Jeff Cislini sells $97,443 in stock - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Revolution Medicines general counsel Jeff Cislini sells $97,443 in stock By Investing.com - Investing.com Australia

Jan 22, 2025
pulisher
Jan 19, 2025

Sandy Cove Advisors LLC Acquires Shares of 42,008 Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Jan 19, 2025

Revolution Medicines Inc (RVMD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):